News

Proposed Bill Aims to Transfer Antitrust Powers from FTC to DOJ

Proposed Bill Aims to Transfer Antitrust Powers from FTC to DOJ

Republican Push to Transfer Antitrust Authority

The U.S. Federal Trade Commission (FTC) is facing challenges to its antitrust enforcement powers. A recent proposal by U.S. Representative Ben Cline aims to shift these powers to the U.S. Department of Justice (DOJ), raising questions about the future of antitrust regulation in the United States.

Understanding the One Agency Act

Cline's initiative, known as the One Agency Act, seeks to eliminate the FTC's authority in antitrust matters. This legislative effort reflects a broader conservative agenda to streamline government functions, a concept that received backing from supporters of former President Donald Trump.

Background of Antitrust Jurisdiction

Historically, the FTC and DOJ have shared jurisdiction over federal antitrust issues for over a century, working collaboratively to prevent anti-competitive practices within various industries. However, recent developments have put this system under scrutiny, especially with incoming challenges to agency powers.

The Impact of the Proposal on Antitrust Enforcement

Cline's proposal has arisen amidst departures in leadership at the FTC. Outgoing Chair Lina Khan's rigorous approach to merger oversight has met resistance, especially from business groups concerned about heightened regulations affecting their operations.

Merger Oversight and Regulatory Challenges

Under the proposed changes, the DOJ would assume full control of antitrust investigations, consolidating responsibilities previously shared with the FTC. This would fundamentally alter how large companies are monitored for compliance with antitrust laws.

The Structure and Potential Changes in Agency Dynamics

The One Agency Act would combine the FTC's Bureau of Competition with the DOJ's antitrust division. This consolidation would represent not just a change in oversight but an opportunity to restructure how federal antitrust efforts are managed.

Concerns Raised by Opponents

Critics of the bill express concern that it would undermine the FTC's ability to protect fair competition, particularly after recent legal actions against influential companies in the tech sector such as Meta Platforms (NASDAQ: META) and Intuit (NASDAQ: INTU). They argue that eliminating the FTC's broad authority would effectively reduce the regulatory oversight necessary to keep the market competitive.

The Political Landscape Surrounding the Bill

The introduction of the One Agency Act was influenced by suggestions from the Heritage Foundation's policy initiatives. Cline, having met with figures like Elon Musk as part of efforts to increase governmental efficiency, believes aligning antitrust powers can lead to better oversight.

The Future of Antitrust Policies

As discussions unfold within Congress, the fate of Cline's proposal remains uncertain. The lack of bipartisan support may hinder its advancement, especially since recent history shows a preference for maintaining a dual-system approach to antitrust enforcement.

Conclusion

As the debate intensifies over the FTC and DOJ's distinct roles, the proposed One Agency Act shines a light on significant questions surrounding antitrust enforcement in the digital age. The transition could reshape the regulatory landscape and affect how large tech companies are governed, stirring ongoing discussions about the balance between industry growth and consumer protection.

Frequently Asked Questions

What is the One Agency Act?

The One Agency Act is a proposal by U.S. Representative Ben Cline to transfer antitrust enforcement authority from the FTC to the DOJ.

Why are conservatives pushing this legislation?

Conservatives aim to streamline government functions and enhance efficiency in antitrust oversight, reflecting a broader political agenda.

What would be the implications of this change for businesses?

If passed, businesses would face a different regulatory environment, with the DOJ managing all antitrust matters, potentially changing compliance dynamics.

Are there opponents to the One Agency Act?

Yes, critics, including some Democrats and legal experts, argue that consolidating authority would weaken antitrust protections against monopolistic practices.

What role has the FTC historically played in antitrust actions?

The FTC has historically shared antitrust responsibilities with the DOJ, focusing on consumer protection and preventing anti-competitive behavior across diverse industries.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 5

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading

Top 5 Most Recently Viewed Articles

Micro Irrigation Systems: The Future of Sustainable Farming

Updated Category News Views 184

Micro Irrigation Systems: Transforming Global Agriculture The micro irrigation systems market is poised for remarkable growth, expected to expand significantly due to the increasing demand for sustainable agricultural practices. These systems are projected to elevate market valuation from USD 10.9 billion to USD 27.4 billion over the next decade, exhibiting a strong CAGR...

Continue Reading
Empowering Communities: Diaspora Groceries Supplier Summit Launch

Updated Category News Views 276

Empowering Communities: Diaspora Groceries Supplier Summit Launch Diaspora Groceries is thrilled to announce its inaugural Diaspora Diversity Supplier Summit, in partnership with its newly established nonprofit arm, Diaspora Groceries Cares. Taking place over two transformative days, the summit invites food suppliers, farmers, and advocates to gather for insightful...

Continue Reading
EMP Metals Unveils Enhanced Resource Estimate for Lithium Projects

Updated Category News Views 95

EMP Metals Reports Updated Resource Estimate EMP Metals Corp. (CSE: EMPS, OTCQB: EMPPF) is thrilled to share an updated Technical Report detailing the resource estimates for its Viewfield and Mansur lithium brine projects. This comprehensive report showcases a remarkable increase in the total resource, significantly boosting both the indicated and inferred lithium...

Continue Reading
Exploring the Impact of Google Cloud in Enterprise Solutions

Updated Category News Views 264

ISG Evaluates Google Cloud Partner Ecosystem Information Services Group (ISG) (Nasdaq: III), a prominent global technology research and advisory firm, is embarking on an in-depth research study that will gauge the effectiveness of service providers in supporting enterprises using the Google Cloud Platform (GCP) for artificial intelligence (AI) and various other workloads....

Continue Reading
HiRO Joins Forces with CHA University for Future of Health

Updated Category News Views 294

HiRO Collaborates with CHA University Bundang Medical Center Harvest Integrated Research Organization (HiRO), a distinguished global clinical research organization (CRO), has recently entered into a strategic partnership with CHA University Bundang Medical Center (CBMC), a highly respected medical institution in South Korea. This collaboration promises to strengthen the...

Continue Reading